查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
週边血管器材市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、最终用户、地区和竞争细分
市场调查报告书
商品编码
1348912

週边血管器材市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、最终用户、地区和竞争细分

Peripheral Vascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 173 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球週边血管器械市场在预测期内将出现令人印象深刻的成长。这可以归因于老年人口的增长以及全球週边血管疾病盛行率的增加。此外，週边血管手术的有利报销方案预计将在预测期内创造利润丰厚的成长。同样，产品批准数量的增加以及糖尿病盛行率的增加是多年来推动市场成长的主要因素。此外，预计烟草消费率的上升将推动多年来市场的成长。 2022年3月，西门子医疗在美国推出了新一代ACUSON AcuNav Volume 4D ICE导管。据该公司称，AcuNav Volume ICE 导管可以治疗以前无法接受结构性心臟手术的患者，从而改变了护理服务。

人口老化

人口老化是推动全球週边血管器械市场成长的关键因素之一。随着年龄的增长，他们更有可能患上周围血管疾病，这会影响心臟和大脑以外的血管。这些疾病包括週边动脉疾病 (PAD)、深部静脉血栓 (DVT) 和静脉功能不全等。此外，老年人往往更容易出现週边血管疾病的併发症，例如截肢、中风和心臟病。这给医疗保健系统造成了巨大的负担，增加了对用于诊断和治疗的周边血管设备的需求。此外，人口老化更容易出现其他合併症，如糖尿病和高血压，这些都是周边血管疾病的危险因子。由于这些慢性疾病的盛行率也随着年龄的增长而增加，因此对治疗这些疾病的周边血管装置的需求也随之增加。

市场概况
预测期 2024-2028
2022 年市场规模 110612万美元
2028 年市场规模 161726万美元
复合年增长率 6.49%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

慢性病盛行率上升

糖尿病和高血压等慢性病是全球週边血管器械市场成长的主要驱动力。这些情况可能会导致周边血管疾病的发生，进而影响心臟和大脑以外的血管。週边血管疾病包括週边动脉疾病（PAD）、深部静脉血栓（DVT）及静脉功能不全等。随着糖尿病、高血压等慢性病在全球的盛行率持续上升，週边血管疾病的发生率也不断上升。根据国际糖尿病联盟的数据，到2045 年，全球糖尿病盛行率预计将从2013 年的8.3% 上升至10.9%。糖尿病是周边血管疾病的重要危险因子，尤其是周边动脉疾病(PAD)，估计影响20% 的人口患有糖尿病。高血压是周边血管疾病的另一个主要危险因子。据世界卫生组织称，高血压影响全球约 11.3 亿人，估计每年导致 940 万人死亡。高血压会损害血管并减少血流量，从而导致周边动脉疾病 (PAD) 和其他週边血管疾病的发生。糖尿病和高血压等慢性病的盛行率不断上升，推动了对用于诊断、治疗和管理週边血管疾病的周边血管器械的需求。这些装置包括支架、导管、球囊以及用于微创手术（例如血管成形术和斑块切除术）的其他装置。

技术进步

技术进步对推动全球週边血管器械市场的成长发挥了重要作用。这些进步导致了新的和改进的设备的开发，以及用于诊断、治疗和管理周围血管疾病的新程序和技术。近年来最重要的进展之一是针对週边血管疾病的微创手术的发展，例如血管成形术和斑块旋切术。这些手术使用小切口和专用工具来治疗阻塞或狭窄的血管，减少开放性手术的需要并最大限度地缩短恢復时间。成像技术的进步也在市场的成长中发挥了关键作用。磁振造影血管摄影（MRA）和电脑断层血管摄影（CTA）等影像技术的改进使得诊断和评估週边血管疾病变得更加容易，从而可以製定更准确的治疗计划。此外，生物可吸收支架、药物洗脱球囊等器械材料也取得了重大进展，提高了周边血管器械的安全性和有效性。推动市场成长的另一个技术进步领域是远距患者监护系统的发展。这些系统允许医疗保健提供者远端监测患有周围血管疾病的患者，减少频繁去医院的需要并改善患者的治疗结果。

增加医疗保健支出

医疗支出是影响全球週边血管器材市场成长的重要因素。随着医疗保健支出的增加，对用于诊断、治疗和管理週边血管疾病的医疗设备（包括週边血管设备）的需求通常也会相应增加。此外，糖尿病和高血压等慢性病的盛行率不断上升，这些疾病是周边血管疾病的重要危险因素，也推动了医疗支出。这些情况需要持续的管理和治疗，包括使用周边血管装置，以预防肢体截肢、中风和心臟病等併发症。此外，随着医疗保健系统努力降低成本和提高效率，人们越来越关注週边血管疾病的预防保健和早期诊断。这导致对筛检和诊断工具的投资增加，例如影像技术和生物标记测试，这有助于及早发现周围血管疾病，并防止以后需要更昂贵的干预措施。

优惠报销政策

报销政策是影响全球週边血管器械市场成长的重要因素。报销政策决定了医疗保健提供者和患者可以从保险公司和政府计划获得的金额，以支付医疗程序和设备（包括週边血管设备）的费用。在许多国家，政府和私人保险计划为患有某些疾病（例如周边动脉疾病或深部静脉栓塞）的患者支付週边血管装置的费用。报销政策对新型和创新週边血管设备的采用具有重大影响，因为提供者和患者更有可能使用保险承保的设备。此外，报销政策的变化可能会对市场的成长产生重大影响。例如，政府或保险公司决定减少週边血管装置的报销可能会导致对这些装置的需求下降。此外，报销政策的复杂性也可能成为市场成长的障碍。获得周边血管装置报销的过程可能既耗时又复杂，这可能会阻止医疗保健提供者使用这些装置。

最近的发展

  • Stellarex PTX DCB - 2022年，飞利浦推出了Stellarex PTX药物涂层球囊，旨在治疗週边动脉疾病患者。该装置使用药物涂层球囊将抗增生药物输送到动脉阻塞部位，降低再狭窄的风险。
  • Tigereye Guidewire - 2022 年，波士顿科学公司推出了 Tigereye Guidewire，这是一种用于在血管内手术期间进入和导航外周脉管系统的设备。导丝具有亲水涂层，增强了其在曲折解剖结构中导航的能力。
  • Luminor35 微导管 - 2022 年，AngioDynamics 推出了 Luminor 35 微导管，旨在促进进入周边脉管系统中的小血管。该设备具有柔性轴和亲水涂层，增强了其导航性和易用性。
  • iCAST Flex 週边支架 - 2022 年，Atrium Medical 推出了 iCAST Flex 週边支架，旨在治疗小腿週边动脉疾病患者。该支架采用镍钛诺线框，使其能够部署在复杂的解剖结构中，同时保持径向强度。
  • VascuFlex Multi-LOC - 2020 年，B. Braun Melsungen AG 推出了 VascuFlex Multi-LOC，这是一种自膨胀式镍钛合金支架系统，设计用于治疗股腘动脉外周动脉疾病。
  • HawkOne 定向斑块切除系统 - 2019 年，美敦力推出了 HawkOne 定向斑块切除系统，该设备旨在清除因週边动脉疾病导致的腿部血管阻塞中的斑块。
  • EnVivo 可扭转微导管 - 2018 年，波士顿科学公司推出了 EnVivo 可扭转微导管，这是一种用于週边血管手术的设备，可将诊断或治疗药物输送到脉管系统内的特定位置。
  • EluNIR 药物洗脱支架系统 - 2018 年，美敦力推出了 EluNIR 药物洗脱支架系统，这是一种设计用于治疗股腘动脉周围动脉疾病的设备。
  • IN.PACT Admiral 药物涂层球囊 - 2018 年，美敦力还推出了 IN.PACT Admiral 药物涂层球囊，该装置用于通过打开狭窄或阻塞的血管并释放药物来预防腿部外周动脉疾病。疤痕组织的形成。

市场区隔

全球週边血管器械市场可以按类型、最终用户、地区和竞争格局进行细分。依类型，市场可分为週边支架、PTA球囊、导管、血管内动脉瘤修补覆膜支架、斑块修饰装置、週边配件、下腔静脉过滤器、血流动力学改变装置。根据最终用户，市场可分为医院、诊所、门诊手术中心。

市场参与者

Abbott Laboratories.、AngioScore Inc.、Edward Lifesciences Corporation.、Medtronic Inc.、St. Jude Medical.、Teleflex Medical.、Volcano Corporation.、Boston Scientific Corporation.、Teleflex Medical.、Cook Group Inc.、Cordis Corporation、Covidien、 WL Gore and Associates Ltd 是全球週边血管器材市场的一些领先参与者。

报告范围：

在本报告中，除了以下详细介绍的产业趋势外，全球週边血管器械市场还分为以下几类：

週边血管器械市场，依类型：

  • 外周支架
  • PTA 气球
  • 导管
  • 血管内动脉瘤修补覆膜支架
  • 斑块修饰装置
  • 週边配件
  • 下腔静脉过滤器
  • 血流动力学流量改变装置

週边血管器械市场，依最终用户划分：

  • 医院
  • 诊所
  • 门诊手术中心

週边血管器械市场（按地区）：

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

竞争格局

公司概况：全球週边血管器械市场主要公司的详细分析。

可用的客製化：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型（週边支架、PTA 球囊、导管、血管内动脉瘤修补覆膜支架、斑块修饰装置、週边配件、下腔静脉过滤器、血流动力学改变装置）
    • 按最终使用者（医院和诊所、门诊手术中心、其他）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按类型
    • 由最终用户
    • 按地区

第 6 章：北美週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲週边血管器械市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非週边血管装置
    • 沙乌地阿拉伯週边血管装置
    • 阿联酋週边血管装置

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球週边血管器械市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Abbott Laboratories, Inc.
    • Angioscore Inc.
    • Edward Lifesciences Corporation.
    • Medtronic Plc.
    • Teleflex Medical.
    • Volcano Corporation.
    • Boston Scientific Corporation.
    • Teleflex Medical.
    • Cook Group Inc.
    • Cordis Corporation

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 15454

Global Peripheral Vascular Devices market is anticipated to witness impressive growth during the forecast period. This can be ascribed to growing geriatric population along with a subsequent increase in the prevalence of peripheral vascular diseases across the globe. Also, the favorable reimbursement scenario for peripheral vascular procedures is expected to create lucrative growth during the forecast period. Similarly, increasing number of product approvals along with the growing prevalence of diabetes are major factors driving the growth of the market over the years. Additionally, rising the rate of tobacco consumption is anticipated to boost the growth of the market over the years. In March 2022, Siemens Healthineers launched next-generation ACUSON AcuNav Volume 4D ICE Catheter in the United States. As per the company, AcuNav Volume ICE catheter transforms care delivery by enabling the treatment of patients who were previously not able to undergo structural heart procedures.

Aging population

The aging population is one of the key factors driving the growth of the global peripheral vascular devices market. As people age, they are more likely to develop peripheral vascular diseases, which can affect the blood vessels outside of the heart and brain. These conditions include peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency, among others. Furthermore, the elderly population is often more susceptible to the complications of peripheral vascular diseases, such as limb amputation, stroke, and heart attack. This creates a significant burden on healthcare systems, increasing the demand for peripheral vascular devices for diagnosis and treatment. In addition, the aging population is more likely to have other comorbidities, such as diabetes and hypertension, which are risk factors for peripheral vascular diseases. As the prevalence of these chronic diseases also increases with age, the demand for peripheral vascular devices to manage these conditions also increases.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1106.12 Million
Market Size 2028USD 1617.26 Million
CAGR (2023-2028)6.49%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Rising prevalence of chronic diseases

Chronic diseases such as diabetes and hypertension are major drivers of the growth of the global peripheral vascular devices market. These conditions can contribute to the development of peripheral vascular diseases, which affect the blood vessels outside of the heart and brain. Peripheral vascular diseases include peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency, among others. As the prevalence of chronic diseases such as diabetes and hypertension continue to increase worldwide, so too does the incidence of peripheral vascular diseases. According to the International Diabetes Federation, the global prevalence of diabetes is expected to reach 10.9% by 2045, up from 8.3% in 2013. Diabetes is a significant risk factor for peripheral vascular diseases, particularly PAD, which affects an estimated 20% of people with diabetes. Hypertension, or high blood pressure, is another major risk factor for peripheral vascular diseases. According to the World Health Organization, hypertension affects around 1.13 billion people worldwide, and is responsible for an estimated 9.4 million deaths each year. Hypertension can contribute to the development of PAD and other peripheral vascular diseases by damaging blood vessels and reducing blood flow. The growing prevalence of chronic diseases such as diabetes and hypertension are driving demand for peripheral vascular devices for diagnosis, treatment, and management of peripheral vascular diseases. These devices include stents, catheters, balloons, and other devices used in minimally invasive procedures such as angioplasty and atherectomy.

Technological advances

Technological advances have played a significant role in driving the growth of the global peripheral vascular devices market. These advances have led to the development of new and improved devices, as well as new procedures and techniques for diagnosis, treatment, and management of peripheral vascular diseases. One of the most significant advances in recent years has been the development of minimally invasive procedures for peripheral vascular diseases, such as angioplasty and atherectomy. These procedures use small incisions and specialized tools to treat blocked or narrowed blood vessels, reducing the need for open surgery and minimizing recovery time. Advances in imaging technology have also played a key role in the growth of the market. Improved imaging techniques such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA) have made it easier to diagnose and assess peripheral vascular diseases, allowing for more accurate treatment planning. In addition, there have been significant advances in device materials, such as bioresorbable stents and drug-eluting balloons, which have improved the safety and efficacy of peripheral vascular devices. Another area of technological advancement that is driving growth in the market is the development of remote patient monitoring systems. These systems allow healthcare providers to monitor patients with peripheral vascular diseases remotely, reducing the need for frequent hospital visits and improving patient outcomes.

Increasing healthcare expenditure

Healthcare expenditure is a significant factor that influences the growth of the global peripheral vascular devices market. As healthcare expenditure increases, there is typically a corresponding increase in demand for medical devices, including peripheral vascular devices, to diagnose, treat, and manage peripheral vascular diseases. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are significant risk factors for peripheral vascular diseases, is also driving healthcare expenditure. These conditions require ongoing management and treatment, including the use of peripheral vascular devices, to prevent complications such as limb amputation, stroke, and heart attack. Furthermore, as healthcare systems strive to reduce costs and improve efficiency, there is a growing focus on preventive care and early diagnosis of peripheral vascular diseases. This has led to increased investment in screening and diagnostic tools, such as imaging technology and biomarker tests, which can help identify peripheral vascular diseases early and prevent the need for more costly interventions later on.

Favorable reimbursement policies

Reimbursement policies are a significant factor that influences the growth of the global peripheral vascular devices market. Reimbursement policies determine the amount of money that healthcare providers and patients can receive from insurance companies and government programs to cover the cost of medical procedures and devices, including peripheral vascular devices. In many countries, government and private insurance programs cover the cost of peripheral vascular devices for patients with certain medical conditions, such as peripheral artery disease or deep vein thrombosis. Reimbursement policies have a significant impact on the adoption of new and innovative peripheral vascular devices, as providers and patients are more likely to use devices that are covered by insurance. Furthermore, changes in reimbursement policies can have a significant impact on the growth of the market. For example, a decision by a government or insurance provider to reduce reimbursement for peripheral vascular devices could lead to a decline in demand for those devices. In addition, the complexity of reimbursement policies can also be a barrier to market growth. The process of obtaining reimbursement for peripheral vascular devices can be time-consuming and complicated, which can deter healthcare providers from using these devices.

Recent Developments

  • Stellarex PTX DCB - In 2022, Philips launched the Stellarex PTX drug-coated balloon, which is designed to treat patients with peripheral artery disease. The device uses a drug-coated balloon to deliver an anti-proliferative drug to the site of the arterial blockage, reducing the risk of restenosis.
  • Tigereye Guidewire - In 2022, Boston Scientific launched the Tigereye Guidewire, a device used to access and navigate through the peripheral vasculature during endovascular procedures. The guidewire features a hydrophilic coating that enhances its ability to navigate through tortuous anatomy.
  • Luminor35 Microcatheter - In 2022, AngioDynamics launched the Luminor 35 microcatheter, which is designed to facilitate access to small vessels in the peripheral vasculature. The device features a flexible shaft and a hydrophilic coating that enhances its navigability and ease of use.
  • iCAST Flex Peripheral Stent - In 2022, Atrium Medical launched the iCAST Flex peripheral stent, which is designed to treat patients with peripheral artery disease in the lower leg. The stent features a nitinol wire frame that allows it to be deployed in complex anatomies, while maintaining radial strength.
  • VascuFlex Multi-LOC - In 2020, B. Braun Melsungen AG launched VascuFlex Multi-LOC, a self-expanding nitinol stent system designed for the treatment of peripheral artery disease in the femoropopliteal arteries.
  • HawkOne Directional Atherectomy System - In 2019, Medtronic launched the HawkOne Directional Atherectomy System, a device designed to remove plaque from blocked blood vessels in the legs due to peripheral artery disease.
  • EnVivo Torqueable Microcatheter - In 2018, Boston Scientific launched the EnVivo Torqueable Microcatheter, a device used in peripheral vascular procedures to deliver diagnostic or therapeutic agents to specific locations within the vasculature.
  • EluNIR Drug-Eluting Stent System - In 2018, Medtronic launched the EluNIR Drug-Eluting Stent System, a device designed for the treatment of peripheral artery disease in the femoropopliteal arteries.
  • IN.PACT Admiral Drug-Coated Balloon - In 2018, Medtronic also launched the IN.PACT Admiral Drug-Coated Balloon, a device used to treat peripheral artery disease in the legs by opening narrowed or blocked blood vessels and releasing a drug to prevent the formation of scar tissue.

Market Segmentation

Global Peripheral Vascular Devices market can be segmented by type, end user, by region and competitive landscape. Based on the type, the market can be segmented into Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices. Based on end user the market can be differentiated into Hospitals, Clinics, Ambulatory Surgical Centers.

Market Players

Abbott Laboratories., AngioScore Inc., Edward Lifesciences Corporation., Medtronic Inc., St. Jude Medical., Teleflex Medical., Volcano Corporation., Boston Scientific Corporation., Teleflex Medical., Cook Group Inc., Cordis Corporation, Covidien, W.L. Gore and Associates Ltd are some of the leading players operating in the Global Peripheral Vascular Devices Market.

Report Scope:

In this report, Global Peripheral Vascular Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peripheral Vascular Devices Market, By Type:

  • Peripheral Stents
  • PTA Balloons
  • Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Plaque Modification Devices
  • Peripheral Accessories
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices

Peripheral Vascular Devices Market, By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Peripheral Vascular Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peripheral Vascular Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peripheral Vascular Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Type
    • 5.3.2 By End Users
    • 5.3.3 By Region

6. North America Peripheral Vascular Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peripheral Vascular Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Peripheral Vascular Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Peripheral Vascular Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Peripheral Vascular Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Peripheral Vascular Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Peripheral Vascular Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Peripheral Vascular Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Peripheral Vascular Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Peripheral Vascular Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Peripheral Vascular Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Peripheral Vascular Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Peripheral Vascular Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Peripheral Vascular Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Peripheral Vascular Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Peripheral Vascular Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Peripheral Vascular Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Peripheral Vascular Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Peripheral Vascular Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Peripheral Vascular Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Peripheral Vascular Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Peripheral Vascular Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Peripheral Vascular Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Peripheral Vascular Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Peripheral Vascular Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Abbott Laboratories, Inc.
    • 15.6.2. Angioscore Inc.
    • 15.6.3. Edward Lifesciences Corporation.
    • 15.6.4. Medtronic Plc.
    • 15.6.5. Teleflex Medical.
    • 15.6.6. Volcano Corporation.
    • 15.6.7. Boston Scientific Corporation.
    • 15.6.8. Teleflex Medical.
    • 15.6.9. Cook Group Inc.
    • 15.6.10. Cordis Corporation

16. Strategic Recommendations

17. About Us & Disclaimer